v3.24.1.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 17,073 $ 12,982
Costs and operating expenses:    
Cost of product revenue 4,855 4,521
Research and development 11,246 16,655
Selling, general and administrative 12,860 15,399
Restructuring charges 0 72
Total costs and operating expenses 28,961 36,647
Loss from operations (11,888) (23,665)
Interest income 909 1,089
Other expense, net (516) (25)
Loss before income taxes (11,495) (22,601)
Provision for income taxes 10 16
Net loss $ (11,505) $ (22,617)
Net loss per share, basic (in dollars per share) $ (0.16) $ (0.34)
Net loss per share, diluted (in dollars per share) $ (0.16) $ (0.34)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 69,854 65,931
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 69,854 65,931
Product revenue    
Revenues:    
Total revenues $ 9,551 $ 8,364
Research and development revenue    
Revenues:    
Total revenues $ 7,522 $ 4,618

Source